Both in Pharmaceuticals
Larimar Therapeutics vs Fulcrum Therapeutics
Over the past year LRMR returned −27.4% and FULC returned −55.0%; their daily moves had a correlation of 0.16.
LRMR −27.4% FULC −55.0%Growth of $1, one year, split-adjusted
| Metric | LRMR | FULC |
|---|---|---|
| Price | $2.76 | $3.77 |
| Market cap | $286.7M | $288.0M |
| Today | +8.66% | +0.80% |
| 1 month | −0.7% | +2.2% |
| 6 months | −33.5% | −47.0% |
| Year to date | −27.6% | −66.7% |
| 1 year | −28.9% | −58.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $156.3M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 15.0% |
| Short % of float | 23.8% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).